Das ist der Job
Protara was named one of the Best Places to Work by BioSpace, a leading industry news and job source.
Darum lohnt es sich
Company Overview Protara Therapeutics is a clinical‑stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases.
Protara’s portfolio includes its lead candidate, TARA-002, an investigational cell‑based therapy in development for the treatment of non‑muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs).
The Company is evaluating TARA-002 in an ongoing Phase 2 trial in NMIBC patients with carcinoma in situ (CIS) who are unresponsive or naïve to treatment with Bacillus Calmette‑Guérin (BCG), as well as a Phase 2 trial in pediatric patients with LMs.
Additionally, Protara is developing IV Choline Chloride, an investigational phospholipid substrate replacement for patients on parenteral support who are otherwise unable to meet their choline needs via oral or enteral routes.
Job Overview The Director, Global Regulatory Affairs leads Protara’s ex‑US regulatory strategy and operational execution for Protara’s clinical studies in oncology, cell and gene therapy, and rare diseases.
The leader will possess ex‑US global submissions experience and manage study specific regulatory submissions and will have country level experience either from the sponsor or CRO side managing global studies. The Director, Global Regulatory Affairs will provide leadership on ex‑US regulatory activities for Protara’s product portfoli
